can you compound semaglutide FDA Warns on Certain Forms of Compounded Compounded Semaglutide Program: Results, Timeline

[15] [16] There is currently no licensed pharmacological treatment for MASLD in the UK, making retatrutide a potentially important therapeutic candidate, though this remains to be confirmed in Phase 3 trials

Both terms refer to synthetic medications that activate the GLP-1 receptor

Dosing protocols Phase 2 clinical trials used a titration schedule starting at 0.5mg weekly, escalating through 1mg, 2mg, 4mg, 8mg, and reaching maintenance doses of up to 12mg weekly over several months

In cases where patients experience difficulty tolerating the 2.4 mg once-weekly dose, a temporary reduction to 1.7 mg once-weekly is permissible, but only for a maximum period of 4 weeks